uMI Panvivo vs VX1+
AI Verdict
Choose uMI Panvivo if…
Choose uMI Panvivo if your institution requires a state-of-the-art, integrated PET/CT imaging system for comprehensive diagnostic precision across oncology, cardiology, and neurology. Its high-resolution imaging and AI-powered workflows are ideal for detailed disease staging, treatment response assessment, and complex neurological evaluations. This system is designed for facilities seeking a scalable, on-premise solution that delivers exceptional image quality and intelligent automation for a broad range of diagnostic needs.
View uMI Panvivo →Choose VX1+ if…
Choose VX1+ if your electrophysiology lab performs cardiac ablation procedures for atrial fibrillation and atrial tachycardia and seeks to enhance real-time decision-making. This AI-powered software integrates seamlessly with existing EP recording and 3D mapping systems to provide immediate identification of abnormal electrograms. It is best suited for electrophysiologists aiming to improve the efficiency and precision of ablation procedures by leveraging AI-driven insights during the intervention itself.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | uMI Panvivo | VX1+ |
|---|---|---|
| Deployment | On-premise | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
VX1+Tool B explicitly highlights a 'simple user interface with color coding' for electrogram dispersion, directly addressing ease of use for the electrophysiologist during a procedure. While Tool A offers features like ambient lighting and collision avoidance for patient comfort and streamlined physical operation, Tool B's focus on a clear and intuitive software interface for its primary clinical user gives it an edge in direct software usability.
Clinical Value
VX1+Tool B (VX1+) has published peer-reviewed clinical study results, such as the Ev-AIFib trial, demonstrating high rates of freedom from atrial fibrillation at one year and robust standardization of ablation outcomes across centers. More recent trials like RESTART also show promising outcomes in complex patient populations. While Tool A (uMI Panvivo) boasts advanced diagnostic precision with high-resolution imaging and AI-powered workflow enhancements, the provided information and search results do not include direct clinical outcome studies demonstrating improved patient treatment success in the same explicit manner as Tool B.
Pricing & Value
uMI PanvivoTool A offers transparent pricing details, including tiered service agreements and lifetime software and functionality upgrades with an active service agreement, providing a clear long-term value proposition. In contrast, Tool B states its pricing is 'not publicly available' and provides no details on its pricing structure or included services, making its value difficult to assess.
Enterprise Readiness
uMI PanvivoTool A explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) available, alongside a scalable deployment model (modality, departmental, or enterprise solution) and a compact design for easier installation. While Tool B integrates with existing EP systems, its HIPAA compliance and BAA availability are not explicitly stated in the provided facts, giving Tool A a stronger position in enterprise readiness.
Innovation
TieBoth tools demonstrate significant innovation in their respective domains. Tool A pushes the boundaries of PET/CT imaging with industry-leading resolution and AI-powered workflows for motion correction and reconstruction. Tool B introduces real-time AI guidance during complex interventional cardiac ablation procedures, providing AI-driven insights to standardize outcomes in a highly operator-dependent field, which is a novel application of AI in live intervention.
Support & Docs
VX1+Tool B explicitly mentions the availability of a 'VX1TM SYSTEM USER MANUAL' in its technical documentation and provides direct contact information for support. While Tool A mentions 'Lifetime software and functionality upgrades included with active service agreement,' which implies ongoing support, it does not explicitly detail available documentation or direct customer support channels in the provided information or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | uMI Panvivo | VX1+ |
|---|---|---|
| Name | uMI Panvivo | VX1+ |
| Company | Shanghai United Imaging Healthcare Co., Ltd. | Volta Medical |
| Description | AI-powered PET/CT system offering advanced diagnostic precision with high-resolution imaging and intelligent workflows for oncology, cardiology, and neurology. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Categories | Cardiology AI, Oncology AI, Radiology & Imaging AI | Cardiology AI, Surgical AI |
| Specialties | Nuclear Medicine, Oncology, Radiology | Cardiology |
| Key Features (Examples) | AI-powered workflow (uVision, EasyRange, OncoFocus, NeuroFocus, uExcel DPR), High NEMA spatial resolution (2.9mm), Exceptional TOF timing resolution (219 ps) | Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart, Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures, AI-driven insights to assist electrophysiologists during ablation procedures |
Videos
Demos, reviews, and walkthroughs featuring uMI Panvivo and VX1+.